Comparison of Utilization Trends between Biosimilars and Generics: Lessons from the Nationwide Claims Data in South Korea

Author:

Lee Hye-JaeORCID,Han EunaORCID,Kim Hyero

Funder

National Research Foundation of Korea

Publisher

Springer Science and Business Media LLC

Subject

Health Policy,Economics and Econometrics,General Medicine

Reference59 articles.

1. Organisation for Economic Co-operation and Development. Health at a Glance 2017. In: OECD Indicaors. OECD Publishing, Paris. 2017. https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2017_health_glance-2017-en. Accessed 28 Jun 2019.

2. Belloni A, Morgan D, Paris V. Pharmaceutical expenditure and policies: past trends and future challenges. OECD Health Working Paper No. 87. Paris: Organisation for Economic Co-operation and Development; 2016.

3. Organisation for Economic Co-operation and Development. Pharmaceutical innovation and access to medicines. In: OECD Health Policy Studies. OECD Publishing, Paris. 2018. https://www.oecd-ilibrary.org/content/publication/9789264307391-en. Accessed 28 Jun 2019.

4. Araujo FC, Goncalves J, Fonseca JE. Pharmacoeconomics of biosimilars: what is there to gain from them? Curr Rheumatol Rep. 2016;18(8):50. https://doi.org/10.1007/s11926-016-0601-0.

5. Haustein R, de Millas C, Hoer A, Haussler B. Saving money in the European healthcare systems with biosimilars. Generics Biosimilars Initiative J. 2012;1(3–4):120–6.

Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3